These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34301487)

  • 21. Comparison of efficacy of HCAG and CAG re-induction chemotherapy in elderly low- and intermediate-risk group patients diagnosed with acute myeloid leukemia.
    Zhang JY; Li L; Liu W; Jin Y; Zhao M; Zhou Y; Fan Z
    Clin Transl Oncol; 2021 Jan; 23(1):48-57. PubMed ID: 32458310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homoharringtonine and omacetaxine for myeloid hematological malignancies.
    Lü S; Wang J
    J Hematol Oncol; 2014 Jan; 7():2. PubMed ID: 24387717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of Homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: a pediatric oncology group study.
    Bell BA; Chang MN; Weinstein HJ
    Med Pediatr Oncol; 2001 Aug; 37(2):103-7. PubMed ID: 11496347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homoharringtonine: history, current research, and future direction.
    Kantarjian HM; Talpaz M; Santini V; Murgo A; Cheson B; O'Brien SM
    Cancer; 2001 Sep; 92(6):1591-605. PubMed ID: 11745238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of induction chemotherapy for patients with high-risk myelodysplastic syndrome (MDS) or MDS-transformed acute myeloid leukemia with CHG regimen and its comparison with regimen GAG and HA].
    Su JY; Chang CK; Zhang X; Zhou LY; Song LQ; Xu L; Wu LY; He Q; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):459-63. PubMed ID: 19379588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and post-induction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from China.
    Huang BT; Zeng QC; Yu J; Liu XL; Xiao Z; Zhu HQ
    Med Oncol; 2012 Mar; 29(1):251-9. PubMed ID: 21258877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of phospho-eIF4E by homoharringtonine eradicates a distinct subset of human acute myeloid leukemia.
    Zhou H; Xu RZ; Gu Y; Shi PF; Qian S
    Leuk Lymphoma; 2020 May; 61(5):1084-1096. PubMed ID: 29334312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment.
    Guo S; Bai X; Shi S; Deng Y; Kang X; An H
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1.
    Zhou M; Zeng J; Wang X; Guo Q; Huang T; Shen H; Fu Y; Wang L; Jia J; Chen C
    J Transl Med; 2013 Oct; 11():265. PubMed ID: 24148180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase.
    O'Brien S; Kantarjian H; Keating M; Beran M; Koller C; Robertson LE; Hester J; Rios MB; Andreeff M; Talpaz M
    Blood; 1995 Nov; 86(9):3322-6. PubMed ID: 7579434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia.
    Feldman E; Arlin Z; Ahmed T; Mittelman A; Puccio C; Chun H; Cook P; Baskind P
    Leukemia; 1992 Nov; 6(11):1189-91. PubMed ID: 1434803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro' growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors.
    Visani G; Russo D; Ottaviani E; Tosi P; Damiani D; Michelutti A; Manfroi S; Baccarani M; Tura S
    Leukemia; 1997 May; 11(5):624-8. PubMed ID: 9180282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.
    Mao C; Fu XH; Yuan JQ; Yang ZY; Huang YF; Ye QL; Wu XY; Hu XF; Zhai ZM; Tang JL
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010248. PubMed ID: 26544114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-delivery of homoharringtonine and doxorubicin boosts therapeutic efficacy of refractory acute myeloid leukemia.
    Yan D; Wei H; Lai X; Ge Y; Xu S; Meng J; Wen T; Liu J; Zhang W; Wang J; Xu H
    J Control Release; 2020 Nov; 327():766-778. PubMed ID: 32949646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
    DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
    Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China.
    Wang J; Lü S; Yang J; Song X; Chen L; Huang C; Hou J; Zhang W
    J Hematol Oncol; 2009 Jul; 2():32. PubMed ID: 19642997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Synergistic effect of azacitidine with homoharringtonine by activating the c-MYC/DDIT3/PUMA axis in acute myeloid leukemia].
    Li J; Huang YQ; Zi J; Song CH; Ge Z
    Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):1001-1009. PubMed ID: 38503523
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis.
    He PF; Zhou JD; Yao DM; Ma JC; Wen XM; Zhang ZH; Lian XY; Xu ZJ; Qian J; Lin J
    Oncotarget; 2017 Jun; 8(25):41498-41507. PubMed ID: 28489568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis.
    Li F; Ye W; Yao Y; Wei W; Lin X; Zhuang H; Li C; Li X; Ling Q; Hu C; Huang X; Qian Y; Mao S; Huang J; Lu Y; Jin J
    J Transl Med; 2023 Feb; 21(1):115. PubMed ID: 36774517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research Progress of Homoharringtonine Effect on IM-resistant Chronic Myelogenous Leukemia -Review].
    Wang Q; Li YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):596-599. PubMed ID: 28446318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.